Marbin Pineda

3.3k citations
31 papers · 1.7k indexed · h-index 22
Topics
BRCA gene mutations in cancer (6 papers)MicroRNA in disease regulation (5 papers)RNA modifications and cancer (5 papers)

In The Last Decade

Marbin Pineda

31 papers receiving 1.7k citations

Peers

Marbin Pineda
Comparison fields: 5 of 90
  • Molecular Biology 965
  • Cancer Research 445
  • Oncology 396
  • Pulmonary and Respiratory Medicine 328
  • Pathology and Forensic Medicine 224
Replace Andrea Mafficini with:
Andrea Mafficini Italy
Bjarni A. Agnarsson Iceland
Ann Koons United States
Masahito Kawazu Japan
Iain Beehuat Tan Singapore
Eirini Pectasides Greece
Linda Kapusta Canada
E. Lin United States
A. John Iafrate United States
Kelly Olino United States
Marbin Pineda relative to Andrea Mafficini Italy Andrea Mafficini's profile →
Citations per field
00.5×1.5×
Andrea Mafficini · 1×
Citations per year

Countries citing papers authored by Marbin Pineda

Since Specialization
Citations

This map shows the geographic impact of Marbin Pineda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marbin Pineda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marbin Pineda more than expected).

Fields of papers citing papers by Marbin Pineda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marbin Pineda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marbin Pineda. The network helps show where Marbin Pineda may publish in the future.

Co-authorship network of co-authors of Marbin Pineda

This figure shows the co-authorship network connecting the top 25 collaborators of Marbin Pineda. A scholar is included among the top collaborators of Marbin Pineda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marbin Pineda. Marbin Pineda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 22
2 59
3 26
4 70
5 204
6 180
7 4
8 128
9 80
10 1
11 33
12 174
13 55
14 37
15 6
16 46
17 49
18 11
19 46
20 64

About Marbin Pineda

Marbin Pineda is a scholar working on Cancer Research, Gastroenterology and Hematology, having authored 31 papers that have together received 1.7k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (6 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Cancer Research (445 citations), Gastroenterology (88 citations) and Genetics (161 citations). Marbin Pineda has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Paul S. Meltzer, Robert L. Walker, Sven Bilke, Yuelin J. Zhu, Sean Davis, Ogan D. Abaan, Lee J. Helman, Joshua J. Waterfall, J. Keith Killian and Princy Francis. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026